Niklas Schultz
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Molecular Biology top 1%
- DNA Repair Mechanisms
- Single-cell and spatial transcriptomics
Papers in
-
- DNA Repair Mechanisms 18
- Single-cell and spatial transcriptomics 3
-
- Cancer Genomics and Diagnostics 2
- Cancer, Hypoxia, and Metabolism 1
- Co-authors
- Thomas Helleday (25 shared papers)Helen E. Bryant (6 shared papers)Mark Meuth (3 shared papers)Huw D. Thomas (2 shared papers)Nicola J. Curtin (2 shared papers)Suzanne Kyle (2 shared papers)Elena López‐Knowles (1 shared paper)Natalia Issaeva (3 shared papers)
- Journals
- Nature Communications (5 papers)Nature (4 papers)Journal of Molecular Biology (2 papers)Molecular and Cellular Biology (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Niklas Schultz
37 papers receiving 8.4k citations
Niklas Schultz's Hit Papers
Peers
Comparison fields: 5 of 106
- Oncology 3.3k
- Molecular Biology 4k
- Cancer Research 677
- Pulmonary and Respiratory Medicine 658
- Genetics 541
Countries citing papers authored by Niklas Schultz
This map shows the geographic impact of Niklas Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niklas Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niklas Schultz more than expected).
Fields of papers citing papers by Niklas Schultz
This network shows the impact of papers produced by Niklas Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niklas Schultz. The network helps show where Niklas Schultz may publish in the future.
Co-authors
The 25 scholars most cited alongside Niklas Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Hit paper breakdown → | 2005 | 4240 |
| 2 | Hydroxyurea-Stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair Hit paper breakdown → | 2010 | 673 |
| 3 | 2009 | 510 | |
| 4 | 2014 | 441 | |
| 5 | 2018 | 413 | |
| 6 | 2005 | 283 | |
| 7 | 2017 | 227 | |
| 8 | 2002 | 197 | |
| 9 | Spatially resolved clonal copy number alterations in benign and malignant tissue Hit paper breakdown → | 2022 | 197 |
| 10 | 2010 | 177 | |
| 11 | 2005 | 150 | |
| 12 | 2015 | 126 | |
| 13 | 2003 | 101 | |
| 14 | 2005 | 91 | |
| 15 | 2021 | 91 | |
| 16 | 2015 | 73 | |
| 17 | 2010 | 64 | |
| 18 | 2013 | 60 | |
| 19 | 2010 | 52 | |
| 20 | 2023 | 49 |
About Niklas Schultz
Niklas Schultz is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 8.5k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (18 papers), PARP inhibition in cancer therapy (6 papers), Prostate Cancer Treatment and Research (5 papers), Microtubule and mitosis dynamics (3 papers), Single-cell and spatial transcriptomics (3 papers), Cancer Genomics and Diagnostics (2 papers), Lipid metabolism and biosynthesis (2 papers) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Oncology (3.3k citations), Molecular Biology (4k citations), Cancer Research (677 citations), Pulmonary and Respiratory Medicine (658 citations) and Genetics (541 citations). Niklas Schultz has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Thomas Helleday, Helen E. Bryant, Mark Meuth, Huw D. Thomas, Nicola J. Curtin, Suzanne Kyle, Elena López‐Knowles, Natalia Issaeva, Eva Petermann and Manuel Luís Orta. Their work appears in journals such as Nature Communications, Nature, Journal of Molecular Biology, Molecular and Cellular Biology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.